Skip to main content
. Author manuscript; available in PMC: 2019 May 11.
Published in final edited form as: Ann Neurol. 2018 May 11;83(5):935–944. doi: 10.1002/ana.25228

Table 1.

Baseline Characteristics of 2137 Participants Who Subsequently Underwent Clinical Evaluation for Incident AD dementia

All
Participants
Mean (SD)
No BP
Meds.
Mean (SD)
BP Meds.

Mean (SD)
No APOE
ε4 Allele
Mean (SD)
Any APOE
ε4 Allele
Mean (SD)

N= 2137 N=913 N=1224 N=1330 N=608
Age (years) 73.1 (5.9) 73.1 (6.0) 73.1 (5.8) 73.4 (5.9) 72.3 (5.5)
Education (years) 13.0 (3.4) 13.2 (3.5) 12.8 (3.3) 12.9 (3.3) 13.0 (3.4)
Systolic BP (mmHg) 138.5 (18.5) 135.6 (17.8) 140.6 (19.5) 139.1 (19.1) 137.9 (18.9)
Diastolic BP (mm Hg) 77.2 (10.5) 76.8 (10.2) 77.5 (10.8) 77.4 (10.4) 77.1 (10.9)
African Americans, % 1165 (55%) 438, 48% 727, 59% 712, 54% 388, 64%
Females, % 1331 (63%) 546 (60%) 785 (64%) 828 (62%) 377 (62%)
APOE, % 608 (31%) 245 (29%) 363 (33%) -- --
BP medication use, % 1224 (57%) -- -- 744 (56%) 363 (60%)
Heart disease, % 243 (11%) 39, 4% 204, 17% 160 (12%) 63 (10%)
Diabetes, % 134 (6%) 23, 3% 111, 9% 87 (7%) 36 (6%)